Pharma readings

By Miguel Tovar | Miguel Tovar created a magazine on Flipboard. “Pharma readings on Flipboard” is available with thousands of other magazines and all the news you care about. Download Flipboard for free and search for “Miguel Tovar”.

Big Pharma And Social Media: How To Avoid Trouble With The FDA

Pharmaceutical companies can use social media to engage and educate patients as well as to provide reliable information about their products. But how do companies tap social media without running afoul of the Food and Drug Administration (FDA) and various regulatory requirements? To find out, I …

Pharma

U.S. FDA panel backs Puma Biotech's breast cancer drug

WASHINGTON (Reuters) - Puma Biotechnology Inc's experimental breast cancer drug reduces the risk of disease recurrence and should be approved, an advisory committee to the U.S. Food and Drug Administration concluded on Wednesday.<p>The panel voted 12 to 4 in favor of the drug, neratinib, saying its …

Cancer

UK biotech boasts Europe's best pipeline as Brexit threat looms

LONDON (Reuters) - Britain's biotech sector boasts the strongest new drug pipeline in Europe but industry leaders say it needs continued access to global talent, funding and regulatory clarity to thrive in the future - all of which could be jeopardized by Brexit.<p>A new report on Wednesday showed …

Brexit

Amgen's Bone Drug Disappointment Shows Limits Of Genetics In Drug Discovery

Last night, Amgen and UCB Pharma announced that although their osteoporosis drug, romosozumab, prevented fractures of the vertebrae in post-menopausal women, it also may have increased the risk of heart attacks by 30%.<p>The Food and Drug Administration was due to make a decision on whether to …

Medicine

AstraZeneca sells Seloken European rights for $300m

Anglo-Swedish group to make and supply beta-blocker to Italian drugmaker Recordati<p>AstraZeneca, the Anglo-Swedish pharmaceuticals group, has sold the …

Medicine

AstraZeneca asthma shot hits goal but diabetes drug lags rival

| LONDON<p>AstraZeneca's experimental injection for severe asthma cut substantially the need for patients to take problematic oral steroid drugs in a late-stage study, boosting hopes for a medicine that is expected to reach the market later this year.<p>But the British drugmaker's established Bydureon …

Medicine

Novartis to cut around 500 jobs in Switzerland, add 350

Novartis plans to cut or transfer around 500 traditional production and development jobs at Swiss sites over the next 18 months and add 350 others, mostly in its biotech business, the drugmaker said on Thursday.<p>Swiss domestic head Matthias Leuenberger gave the figures in an interview posted on the …

World News

Pfizer drug from Medivation deal shows promise in breast cancer: study

(Reuters) - A breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior treatments and a modest ability to hold the disease in check, according to data from a mid-stage study released on Wednesday.<p>The drug, …

Cancer

GE Partners With Harvard Hospitals To Harness Artificial Intelligence In Medicine

General Electric’s healthcare division will partner with the corporate parent of two of Harvard University’s teaching hospitals to develop artificial intelligence products for medicine. The goal: to leverage the company’s dominant position in medical imaging into a new ownership of medical AI.<p>“We …

Artificial Intelligence

Big pharma hopes rule change will ease China sales pain

Growing appetite for branded drugs expected to offset plunge in prices<p>The world’s largest pharmaceutical companies, which are struggling with pricing …

China

How AstraZeneca cancer drug forecasts are set to rise

| LONDON<p>Sales forecasts for AstraZeneca's all-important new cancer immunotherapy drug Imfinzi are set to rise after the drugmaker received an unexpectedly early boost for the medicine in lung cancer last week.<p>Consensus sales forecast compiled before Friday's news of the drug's success in stage III …

Cancer

Trump’s new FDA commissioner has a huge decision to make

<i>William B. Schultz is a partner at the law firm Zuckerman Spaeder, former general counsel of the Department of Health and Human Services during the Obama administration and former deputy commissioner for policy of the Food and Drug Administration during the Clinton administration.</i><p>Last week, the …

Pharma

Pharma's Not So Stingy With R&D After All

Many pharma critics argue that drug companies skimp on research while earning outsized revenues – but a new analysis my colleague and I just published tells a more nuanced story.<p>First, some background. Journalists and academics often point to the fraction of revenues that drug companies spend on …

Stocks

AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next

Shares in AstraZeneca are up 9% to $33.82 after the London-based drug giant announced that its cancer drug Imfinzi worked in a clinical trial to slow the progression of lung tumors in patients whose cancer was not treatable with surgery, capping off a week that’s driven home a clear message about a …

Cancer

Novo Nordisk bets on new obesity drug recipes

LONDON (Reuters) - Hit by pricing pressure in its core insulin business, Danish drugmaker Novo Nordisk is looking at new treatments for obesity - a major cause of diabetes - to help revive its growth.<p>New Chief Executive Lars Fruergaard Jorgensen, who took over in January, admits obesity has been a …

Pharma

How Big Pharma Might Be Cut Down To Size

“Pigs get fat, but hogs get slaughtered,” the saying goes. And so may it prove to be true for the pharmaceutical industry.<p>Three articles, all published May 3, illustrate the greed and egregious pricing by certain drug companies that are gaining public recognition and scrutiny.<p>Marathon …

Pharma

Merck boosted by FDA approval for Keytruda use with chemo

Merck shares ticked up on Wednesday evening after US drug regulators cleared the use of its immunotherapy drug Keytruda in combination with …

Cancer

Novo Nordisk Sees More Competition in U.S. Drug Prices

Lars Fruergaard Jorgensen, chief executive officer at Novo Nordisk, discusses drug affordability, price caps and his strategy for growth. He speaks …

Diabetes

Eli Lilly raised prices on 9 drugs last week

Indianapolis drug giant Eli Lilly raised list prices of nine of its medicines last week between 6 and 10 percent, according to data obtained by …

Pharma

Sanofi says has no "absolute need" to do acquisitions

| PARIS<p>Sanofi is currently looking at several external growth opportunities, after having failed to clinch two large deals recently, but feels it has no urgent need to make acquisitions, the drugmaker's chairman told shareholders on Wednesday.<p>"There is a certain number of targets that we are …

Stocks

Pfizer immuno-oncology drug wins U.S. approval for bladder cancer

(Reuters) - U.S. health regulators on Tuesday granted accelerated approval for Pfizer Inc's immuno-oncology drug Bavencio to treat advanced bladder cancer, marking the second approval in less than two months for the treatment developed along with Germany's Merck KGaA.<p>Bavencio, known chemically as …

Cancer

Drug maker Sanofi says it will tie price increases to health spending

French pharmaceutical giant Sanofi SA, which became a major player in Boston area biotech when it bought Genzyme Corp. in 2011, is unveiling a drug …

Pharma

Trump's Pick to Lead FDA Is Confirmed by U.S. Senate - Bloomberg

The U.S. Senate confirmed Scott Gottlieb as President Donald Trump’s nominee to lead the Food and Drug Administration, putting in place a …

Pharma

Drug Lobby Said to Mull Membership Cuts Amid Price Scrutiny - Bloomberg

The pharmaceutical industry’s Washington lobbying group will likely adopt new membership rules this week that will oust many smaller companies that …

Pharma

Big Pharma Losing Leverage as Payers Raise Pressure on Price - Bloomberg

Being a big drug company isn’t what it used to be.<p>The largest drugmakers are finding it more difficult to charge high prices for a range of …

Pharma

Pfizer to give out breast cancer drug free while awaiting NHS decision

Pharmaceutical firm says it will offer palbociclib to patients while regulator rules on whether it should be available on NHS<p>A drug described as one of the most important advances in treating breast cancer in the past 20 years is to be given to women in the UK for free while the medicines regulator …

Cancer

Drug Prices Are Growing At The Slowest Rate In Years. Here's Why It Doesn't Feel That Way

Out-of-pocket drug costs.<p>You’d think, from the political clamor, that the cost of prescription drugs is rising out of control. But actually, growth in drug prices this year was half of last year, according to a new report from The QuintilesIMS Institute, an arm of a gigantic pharmaceutical industry …

Pharma

Still Some Uncertainty Surrounding Bristol-Myers Squibb

, Contributor<p>Bristol-Myers Squibb‘s stock has inched up a little following its Q1 2017 earnings release last week, as the company reported better than expected results. Its key cancer drug Opdivo grew nearly 60% despite competitive challenges, and blood thinner Eliquis continued its uptake, …

Cancer

Novartis, Roche back French gene therapy start-up Vivet

(Reuters) - French gene therapy start-up Vivet Therapeutics said on Thursday it had raised 37.5 million euros ($41 million) in an initial financing round, with backing from the venture arms of Swiss drugmakers Novartis and Roche.<p>Other investors include Columbus Venture Partners, HealthCap, Kurma …

Genetics